Venture Medical, LLC, a leader in wound care solutions, announces its acquisition of certain assets of ProgenaCare Global, LLC, a biotechnology company known for its innovative, keratin-based wound healing technologies, including ProgenaMatrix® and intellectual property underlying an expected future product line. By integrating ProgenaCare’s proprietary keratin platform, Venture Medical enhances its advanced therapy portfolio with regenerative technologies that accelerate healing and improve outcomes for patients with chronic and hard-to-heal wounds.
Read the full article: Venture Medical Announces Acquisition of Certain Assets of ProgenaCare Global to Expand Advanced Wound Care Portfolio //
Source: https://www.einpresswire.com/article/816841109/venture-medical-announces-acquisition-of-certain-assets-of-progenacare-global-to-expand-advanced-wound-care-portfolio